<!doctype html><html><head><meta name="viewport" content="width=device-width, initial-scale=1"/><title>How is the world doing in its fight against vaccine preventable diseases? - Our World in Data</title><meta name="description" content="This week – 24-30 April – is World Immunization Week. The theme of this year&#x27;s World Immunization Week is collective action to protect every person in the world from &quot;vaccine-preventable diseases&quot; (VPDs). VPDs are 25 viral and bacterial diseases listed by the World Health Organization (WHO) that can be prevented by vaccination. "/><link rel="canonical" href="https://mispytest-owid.netlify.com/vaccine-preventable-diseases"/><link rel="alternate" type="application/atom+xml" href="/atom.xml"/><meta property="fb:app_id" content="1149943818390250"/><meta property="og:url" content="https://mispytest-owid.netlify.com/vaccine-preventable-diseases"/><meta property="og:title" content="How is the world doing in its fight against vaccine preventable diseases?"/><meta property="og:description" content="This week – 24-30 April – is World Immunization Week. The theme of this year&#x27;s World Immunization Week is collective action to protect every person in the world from &quot;vaccine-preventable diseases&quot; (VPDs). VPDs are 25 viral and bacterial diseases listed by the World Health Organization (WHO) that can be prevented by vaccination. "/><meta property="og:image" content="https://owid.cloud/wp-content/uploads/2018/04/Reduction-of-child-deaths-due-to-vaccine-preventable-diseases-v2-2.png"/><meta property="og:site_name" content="Our World in Data"/><meta name="twitter:card" content="summary_large_image"/><meta name="twitter:site" content="@OurWorldInData"/><meta name="twitter:creator" content="@OurWorldInData"/><meta name="twitter:title" content="How is the world doing in its fight against vaccine preventable diseases?"/><meta name="twitter:description" content="This week – 24-30 April – is World Immunization Week. The theme of this year&#x27;s World Immunization Week is collective action to protect every person in the world from &quot;vaccine-preventable diseases&quot; (VPDs). VPDs are 25 viral and bacterial diseases listed by the World Health Organization (WHO) that can be prevented by vaccination. "/><meta name="twitter:image" content="https://owid.cloud/wp-content/uploads/2018/04/Reduction-of-child-deaths-due-to-vaccine-preventable-diseases-v2-2.png"/><link href="https://fonts.googleapis.com/css?family=Lato:300,400,400i,700,700i|Playfair+Display:400,700" rel="stylesheet"/><link rel="stylesheet" href="https://mispytest-owid.netlify.com/assets/css/commons.css"/><link rel="stylesheet" href="https://mispytest-owid.netlify.com/assets/css/owid.css"/></head><body class="single-post "><header class="site-header"><div class="wrapper site-navigation-bar"><div class="site-logo"><a href="/">Our World<br/> in Data</a></div><nav class="site-navigation lg-only"><div class="topics-button-wrapper"><a href="/#entries" class="topics-button"><div class="label">Research <br/><strong>by topic</strong></div><div class="icon"><svg width="12" height="6"><path d="M0,0 L12,0 L6,6 Z" fill="currentColor"></path></svg></div></a></div><div><div class="site-primary-navigation"><form class="HeaderSearch" action="/search" method="GET"><input type="search" name="q" placeholder="Search..."/><div class="icon"><svg aria-hidden="true" data-prefix="fas" data-icon="search" class="svg-inline--fa fa-search fa-w-16 " role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><path fill="currentColor" d="M505 442.7L405.3 343c-4.5-4.5-10.6-7-17-7H372c27.6-35.3 44-79.7 44-128C416 93.1 322.9 0 208 0S0 93.1 0 208s93.1 208 208 208c48.3 0 92.7-16.4 128-44v16.3c0 6.4 2.5 12.5 7 17l99.7 99.7c9.4 9.4 24.6 9.4 33.9 0l28.3-28.3c9.4-9.4 9.4-24.6.1-34zM208 336c-70.7 0-128-57.2-128-128 0-70.7 57.2-128 128-128 70.7 0 128 57.2 128 128 0 70.7-57.2 128-128 128z"></path></svg></div></form><ul class="site-primary-links"><li><a href="/blog">Blog</a></li><li><a href="/about">About</a></li><li><a href="/donate">Donate</a></li></ul></div><div class="site-secondary-navigation"><ul class="site-secondary-links"><li><a href="/charts">All charts</a></li><li><a href="/teaching">Teaching material</a></li><li><a href="https://sdg-tracker.org">Sustainable Development Goals</a></li></ul></div></div></nav><ul class="site-social-links lg-only"><li><a href="https://twitter.com/ourworldindata" target="_blank" rel="noopener noreferrer" title="Follow us on Twitter"><svg aria-hidden="true" data-prefix="fab" data-icon="twitter" class="svg-inline--fa fa-twitter fa-w-16 " role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><path fill="currentColor" d="M459.37 151.716c.325 4.548.325 9.097.325 13.645 0 138.72-105.583 298.558-298.558 298.558-59.452 0-114.68-17.219-161.137-47.106 8.447.974 16.568 1.299 25.34 1.299 49.055 0 94.213-16.568 130.274-44.832-46.132-.975-84.792-31.188-98.112-72.772 6.498.974 12.995 1.624 19.818 1.624 9.421 0 18.843-1.3 27.614-3.573-48.081-9.747-84.143-51.98-84.143-102.985v-1.299c13.969 7.797 30.214 12.67 47.431 13.319-28.264-18.843-46.781-51.005-46.781-87.391 0-19.492 5.197-37.36 14.294-52.954 51.655 63.675 129.3 105.258 216.365 109.807-1.624-7.797-2.599-15.918-2.599-24.04 0-57.828 46.782-104.934 104.934-104.934 30.213 0 57.502 12.67 76.67 33.137 23.715-4.548 46.456-13.32 66.599-25.34-7.798 24.366-24.366 44.833-46.132 57.827 21.117-2.273 41.584-8.122 60.426-16.243-14.292 20.791-32.161 39.308-52.628 54.253z"></path></svg></a></li><li><a href="https://www.facebook.com/OurWorldinData/" target="_blank" rel="noopener noreferrer" title="Subscribe to our Facebook page"><svg aria-hidden="true" data-prefix="fab" data-icon="facebook" class="svg-inline--fa fa-facebook fa-w-14 " role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512"><path fill="currentColor" d="M448 56.7v398.5c0 13.7-11.1 24.7-24.7 24.7H309.1V306.5h58.2l8.7-67.6h-67v-43.2c0-19.6 5.4-32.9 33.5-32.9h35.8v-60.5c-6.2-.8-27.4-2.7-52.2-2.7-51.6 0-87 31.5-87 89.4v49.9h-58.4v67.6h58.4V480H24.7C11.1 480 0 468.9 0 455.3V56.7C0 43.1 11.1 32 24.7 32h398.5c13.7 0 24.8 11.1 24.8 24.7z"></path></svg></a></li><li><a href="/subscribe" target="_blank" rel="noopener noreferrer" title="Subscribe to our newsletter"><svg aria-hidden="true" data-prefix="fas" data-icon="envelope" class="svg-inline--fa fa-envelope fa-w-16 " role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><path fill="currentColor" d="M502.3 190.8c3.9-3.1 9.7-.2 9.7 4.7V400c0 26.5-21.5 48-48 48H48c-26.5 0-48-21.5-48-48V195.6c0-5 5.7-7.8 9.7-4.7 22.4 17.4 52.1 39.5 154.1 113.6 21.1 15.4 56.7 47.8 92.2 47.6 35.7.3 72-32.8 92.3-47.6 102-74.1 131.6-96.3 154-113.7zM256 320c23.2.4 56.6-29.2 73.4-41.4 132.7-96.3 142.8-104.7 173.4-128.7 5.8-4.5 9.2-11.5 9.2-18.9v-19c0-26.5-21.5-48-48-48H48C21.5 64 0 85.5 0 112v19c0 7.4 3.4 14.3 9.2 18.9 30.6 23.9 40.7 32.4 173.4 128.7 16.8 12.2 50.2 41.8 73.4 41.4z"></path></svg></a></li></ul><div class="site-navigation sm-only"><button class="button"><svg aria-hidden="true" data-prefix="fas" data-icon="search" class="svg-inline--fa fa-search fa-w-16 " role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><path fill="currentColor" d="M505 442.7L405.3 343c-4.5-4.5-10.6-7-17-7H372c27.6-35.3 44-79.7 44-128C416 93.1 322.9 0 208 0S0 93.1 0 208s93.1 208 208 208c48.3 0 92.7-16.4 128-44v16.3c0 6.4 2.5 12.5 7 17l99.7 99.7c9.4 9.4 24.6 9.4 33.9 0l28.3-28.3c9.4-9.4 9.4-24.6.1-34zM208 336c-70.7 0-128-57.2-128-128 0-70.7 57.2-128 128-128 70.7 0 128 57.2 128 128 0 70.7-57.2 128-128 128z"></path></svg></button><button class="button"><svg aria-hidden="true" data-prefix="fas" data-icon="bars" class="svg-inline--fa fa-bars fa-w-14 " role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512"><path fill="currentColor" d="M16 132h416c8.837 0 16-7.163 16-16V76c0-8.837-7.163-16-16-16H16C7.163 60 0 67.163 0 76v40c0 8.837 7.163 16 16 16zm0 160h416c8.837 0 16-7.163 16-16v-40c0-8.837-7.163-16-16-16H16c-8.837 0-16 7.163-16 16v40c0 8.837 7.163 16 16 16zm0 160h416c8.837 0 16-7.163 16-16v-40c0-8.837-7.163-16-16-16H16c-8.837 0-16 7.163-16 16v40c0 8.837 7.163 16 16 16z"></path></svg></button></div></div></header><main><header class="blog-header"><h1><a href="/blog">Blog</a></h1></header><div class="site-content"><article class="post"><header class="articleHeader"><h1 class="entry-title">How is the world doing in its fight against vaccine preventable diseases?</h1><div class="entry-meta"><time>April 24, 2018</time> by Samantha Vanderslott</div></header><div class="article-content"><section><p><span style="font-weight: 400;">This week &#x2013; 24-30 April &#x2013; is <em>World Immunization Week</em>. The theme of this year&apos;s World Immunization Week is collective action to protect every person in the world from &quot;vaccine-preventable diseases&quot; (VPDs). VPDs are </span><a href="http://www.who.int/immunization/global_vaccine_action_plan/GVAP_doc_2011_2020/en/" target="_blank" rel="noopener"><span style="font-weight: 400;">25 viral and bacterial diseases</span></a><span style="font-weight: 400;"> listed by the <em>World Health Organization</em> (WHO) that can be prevented by vaccination. </span></p><p><span style="font-weight: 400;">Not only can individual deaths be avoided, but transmission of infectious diseases can also be interrupted if vaccination rates are high enough. This means that even those who are not vaccinated also gain protection.<a id="ref-1" class="ref" href="#note-1"><sup>1</sup></a> The ultimate goal in public health is often seen to be the eradication of disease through vaccination, as has been achieved for smallpox and it is in close sight for </span><span style="font-weight: 400;">polio. T</span>he world was able to reduce the number of paralytic polio cases from over 350,000 per year in the 1980s to just 42 cases in a year, as we show in <a href="https://owid.cloud/polio/">our entry on polio</a><span style="font-weight: 400;">.</span></p><p><span style="font-weight: 400;">The WHO estimates that </span><a href="http://www.who.int/mediacentre/news/releases/2017/infants-worldwide-vaccinations/en/" target="_blank" rel="noopener"><span style="font-weight: 400;">2 to 3 million deaths</span></a><span style="font-weight: 400;"> are prevented every year through immunization against diphtheria, tetanus, whooping cough, and measles</span><span style="font-weight: 400;">.<a id="ref-2" class="ref" href="#note-2"><sup>2</sup></a>&#xA0;</span><span style="font-weight: 400;">Nonetheless, the WHO also estimates that VPDs are still responsible for </span><a href="http://www.who.int/mediacentre/commentaries/vaccine-preventable-diseases/en/" target="_blank" rel="noopener"><span style="font-weight: 400;">1.5 million deaths</span></a><span style="font-weight: 400;"> each year. </span></p><p><span style="font-weight: 400;">In the chart below we see the global number of deaths of children younger than 5 years per year from 1990 to 2015. The number of deaths which are wholly or partially preventable by vaccines are shown in color.<a id="ref-3" class="ref" href="#note-3"><sup>3</sup></a> The chart shows that the reductions in child deaths over this 25-year period were primarily achieved by a reduction of the number of deaths from vaccine-preventable diseases: The decline in causes which are not vaccine preventable has been modest, while the number of child deaths caused by diseases for which vaccines are available declined from 5.1 million deaths in 1990 to 1.5 million deaths 25 years later.</span></p><p><a href="https://owid.cloud/uploads/2018/04/Reduction-of-child-deaths-due-to-vaccine-preventable-diseases-v2-2.png" target="_blank"><img class="wp-image-18807 size-large aligncenter" src="https://owid.cloud/uploads/2018/04/Reduction-of-child-deaths-due-to-vaccine-preventable-diseases-v2-2-750x525.png" alt="Reduction of child deaths due to vaccine preventable diseases v2 2" width="750" height="525" srcset="/wp-content/uploads/2018/04/Reduction-of-child-deaths-due-to-vaccine-preventable-diseases-v2-2-32x32.png 32w, /wp-content/uploads/2018/04/Reduction-of-child-deaths-due-to-vaccine-preventable-diseases-v2-2-50x50.png 50w, /wp-content/uploads/2018/04/Reduction-of-child-deaths-due-to-vaccine-preventable-diseases-v2-2-64x64.png 64w, /wp-content/uploads/2018/04/Reduction-of-child-deaths-due-to-vaccine-preventable-diseases-v2-2-96x96.png 96w, /wp-content/uploads/2018/04/Reduction-of-child-deaths-due-to-vaccine-preventable-diseases-v2-2-128x128.png 128w, /wp-content/uploads/2018/04/Reduction-of-child-deaths-due-to-vaccine-preventable-diseases-v2-2-150x105.png 150w, /wp-content/uploads/2018/04/Reduction-of-child-deaths-due-to-vaccine-preventable-diseases-v2-2-400x280.png 400w, /wp-content/uploads/2018/04/Reduction-of-child-deaths-due-to-vaccine-preventable-diseases-v2-2-750x525.png 750w, /wp-content/uploads/2018/04/Reduction-of-child-deaths-due-to-vaccine-preventable-diseases-v2-2-768x538.png 768w, /wp-content/uploads/2018/04/Reduction-of-child-deaths-due-to-vaccine-preventable-diseases-v2-2.png 3000w" sizes="(min-width: 800px) 50vw, 100vw"></a></p><p><span style="font-weight: 400;">Two vaccines are responsible for saving millions each year: &#x2018;DTP&#x2019; against diphtheria, tetanus, and pertussis (whooping cough) and &#x2018;MMR&#x2019; against measles, mumps, and rubella.<a id="ref-4" class="ref" href="#note-4"><sup>4</sup></a> Before the measles vaccine was introduced in 1963, measles caused a large number of deaths globally, estimated at </span><a href="http://www.who.int/mediacentre/factsheets/fs286/en/" target="_blank" rel="noopener"><span style="font-weight: 400;">2.6 million each year</span></a><span style="font-weight: 400;">. &#xA0;Because about 86% of the </span><a href="http://www.who.int/mediacentre/factsheets/fs378/en/"><span style="font-weight: 400;">world population is immunized today,</span></a><span style="font-weight: 400;"> the number of people killed by measles have been cut dramatically to an estimated 68,000 deaths in 2016. Tetanus and pertussis were also previously much bigger killers, with pertussis affecting&#xA0;especially children younger than 5 years and tetanus striking newborns (</span><a href="http://www.who.int/immunization/diseases/tetanus/en/"><span style="font-weight: 400;">killing an estimated 787,000 newborns</span></a><span style="font-weight: 400;"> in 1988, compared with 49,000 in 2013</span><span style="font-weight: 400;">).</span></p><h3 id="the-way-ahead"><a class="deep-link" href="#the-way-ahead"></a>The way ahead</h3><p><span style="font-weight: 400;">However, the gains in global vaccination coverage have slowed down slightly in the last few years. The WHO estimates that&#xA0;</span><a href="http://www.who.int/mediacentre/factsheets/fs378/en/"><span style="font-weight: 400;">19.5 million infants</span></a><span style="font-weight: 400;"> worldwide are still at risk of VPDs because they miss out on basic vaccines.<a id="ref-5" class="ref" href="#note-5"><sup>5</sup></a></span></p><p><span style="font-weight: 400;">In addition, all the recommended doses of a vaccine need to be received for it to be most effective. In the case of measles three vaccine doses are recommended. Even though an estimated </span><span style="font-weight: 400;">85% of children receive their first dose of the vaccine, <a href="http://www.who.int/mediacentre/factsheets/fs378/en/" target="_blank" rel="noopener">this drops to 64%</a> for the second dose.</span> <span style="font-weight: 400;">Therefore, it is not only lack of vaccination that is a problem, but it is under-vaccination that leads to deaths from VPDs.</span></p><p><span style="font-weight: 400;">What then are the most deadly VPDs? Which diseases continue to kill the most people? </span></p><h3 id="the-three-most-deadly-diseases"><a class="deep-link" href="#the-three-most-deadly-diseases"></a><b>The three most deadly diseases</b></h3><p><b>Tuberculosis:</b><span style="font-weight: 400;"> Determining which are the most deadly VPDs requires acknowledging that some vaccinations are more effective than others. While most vaccines included in national routine schedules are highly effective, a better vaccine for tuberculosis (TB) is desperately needed. It is Sub-Saharan Africa and parts of Asia in particular that are affected by TB, as the world map below shows.</span></p><figure data-grapher-src="https://mispytest-owid.netlify.com/grapher/tuberculosis-death-rates" class="grapherPreview"><a href="https://mispytest-owid.netlify.com/grapher/tuberculosis-death-rates" target="_blank"><div><img src="https://mispytest-owid.netlify.com/exports/tuberculosis-death-rates_v1_850x600.svg"></div></a></figure><p><span style="font-weight: 400;">The vaccine for TB &#x2013; Bacillus Calmette&#x2013;Gu&#xE9;rin (BCG) &#x2013; has been in use for nearly 100 years. It protects against severe forms of TB but is </span><a href="https://wellcome.ac.uk/news/world-immunisation-week-seven-vaccine-challenges" target="_blank" rel="noopener"><span style="font-weight: 400;">not effective against pulmonary TB</span></a><span style="font-weight: 400;"> (in the lungs) and has variable effectiveness against TB in adults.<a id="ref-6" class="ref" href="#note-6"><sup>6</sup></a><sup>,</sup><a id="ref-7" class="ref" href="#note-7"><sup>7</sup></a> Furthermore, resistance of antibiotics used to treat TB is increasing, meaning some people can no longer be cured by drugs. The estimated number of people in 2016 with </span><a href="http://www.who.int/features/qa/79/en/"><span style="font-weight: 400;">multi-drug resistant TB was 490,000</span></a><span style="font-weight: 400;">. </span></p><p><span style="font-weight: 400;">The fact that there is not a fully effective vaccine and that antibiotic treatment is facing serious difficulties makes TB the most deadly VPD, as we see in the chart below. This chart shows the latest data on the number of deaths from VPDs. In 2016 more than 1 million people died as a result of TB.</span></p><figure data-grapher-src="https://mispytest-owid.netlify.com/grapher/Deaths-caused-by-vaccine-preventable-diseases-over-time" class="grapherPreview"><a href="https://mispytest-owid.netlify.com/grapher/Deaths-caused-by-vaccine-preventable-diseases-over-time" target="_blank"><div><img src="https://mispytest-owid.netlify.com/exports/Deaths-caused-by-vaccine-preventable-diseases-over-time_v2_850x600.svg"></div></a></figure><p><span style="font-weight: 400;">Meningococcal meningitis and hepatitis B are the next most deadly VPDs &#x2013; both causing over 100,000 deaths each in 2016. </span></p><p><b>Meningococcal Meningitis: </b><span style="font-weight: 400;">Despite the introduction of <em>MenAfriVac</em> in 2010, an effective vaccine against the most common type of meningitis in that region, meningococcal meningitis killed almost 130,000 people in 2016. Many cases occur in the so-called &#x2018;meningitis belt&#x2019; of sub-Saharan Africa, crossing from Senegal to Ethiopia. Not all the countries in the meningitis belt have implemented mass vaccination campaigns for <em>MenAfriVac</em> and also do not benefit from the expensive <em>MenACWY</em> vaccine introduced into richer countries to protect against other types of meningococcal meningitis.<a id="ref-8" class="ref" href="#note-8"><sup>8</sup></a><sup>,</sup><a id="ref-9" class="ref" href="#note-9"><sup>9</sup></a></span></p><p><b>Hepatitis B:</b><span style="font-weight: 400;"> The vaccine against hepatitis B is also very effective (</span><a href="http://www.who.int/mediacentre/factsheets/fs141/en/" target="_blank" rel="noopener"><span style="font-weight: 400;">an estimated 95% effectiv</span><span style="font-weight: 400;">eness</span></a><span style="font-weight: 400;"> in preventing disease</span><span style="font-weight: 400;">), meaning increased vaccination could lead to a significant reduction in deaths. Still, global coverage of the hepatitis B vaccine is lagging. In 2015, while <a href="http://www.who.int/mediacentre/factsheets/fs141/en/" target="_blank" rel="noopener">84% coverage was reached</a> for the </span><span style="font-weight: 400;">third dose of the vaccine, the coverage for the birth </span><span style="font-weight: 400;">dose</span><span style="font-weight: 400;"> was only 39%</span><span style="font-weight: 400;">. Estimates from mathematical models have shown that if infant coverage would reach 90%, and the first dose administered at birth, 84% of global hepatitis B-related deaths could be prevented.<a id="ref-10" class="ref" href="#note-10"><sup>10</sup></a></span></p><p>There are even more<span style="font-weight: 400;"> deadly diseases for which there are vaccines that can prevent some (but not all) deaths &#x2013; we focus on these in the &apos;additional discussion&apos; below. </span></p><p><span style="font-weight: 400;">In World Immunization Week it is a good moment to look at what we have achieved and what we have to work on next. That 2 to 3 million deaths each year are prevented through immunization shows the capability and imperative of vaccination. The prospect that vaccines could prevent an additional 1.5 million deaths each year makes clear what is within reach if the efforts to fight VBDs are continued.</span></p><hr style="margin: 10px 0px 20px;"><div style="font-size: .7em; color: #4a3737;">
<p><em>Additional discussion: </em></p>
<section><h2 id="which-other-deadly-diseases-can-be-prevented-by-vaccines"><a class="deep-link" href="#which-other-deadly-diseases-can-be-prevented-by-vaccines"></a>Which other deadly diseases can be prevented by vaccines?</h2><p><span style="font-weight: 400;">Deadly diseases that can be prevented by vaccines include diarrheal diseases and lower respiratory diseases: Rotavirus vaccines can protect against rotavirus infections that are the </span><span style="font-weight: 400;"><a href="https://www.cdc.gov/vaccines/hcp/vis/vis-statements/rotavirus.html" target="_blank" rel="noopener">leading causes of severe diarrhea</a> in young children</span><span style="font-weight: 400;">. However, the vaccine does not work as well in low-income countries in Africa and Asia (for reasons that remain unclear but hypotheses include a difference in behavior of oral vaccines in the gut)<a id="ref-11" class="ref" href="#note-11"><sup>11</sup></a> and getting these vaccines to those who need them the most is challenging. A <em>&quot;cold chain&quot;</em> is often required to keep vaccines at the right temperature to be safe and effective &#x2013; this is particularly <a href="https://wellcome.ac.uk/news/world-immunisation-week-seven-vaccine-challenges" target="_blank" rel="noopener">difficult in</a> </span><span style="font-weight: 400;">rural areas or if there is not a constant electricity supply</span><span style="font-weight: 400;">. </span></p><p><span style="font-weight: 400;">There are also vaccines that protect against pneumococcus diseases (including pneumonia, meningitis and febrile bacteraemia) and </span><i><span style="font-weight: 400;">Haemophilus influenzae</span></i><span style="font-weight: 400;"> type b (Hib), which cause pneumonia and lower respiratory infections. These vaccines are available but not yet in widespread use in several countries including China, India, Nigeria, Bangladesh, Afghanistan, and Indonesia.<a id="ref-12" class="ref" href="#note-12"><sup>12</sup></a> Global coverage <a href="http://www.who.int/mediacentre/factsheets/fs378/en/" target="_blank" rel="noopener">is estimated at</a> </span><span style="font-weight: 400;">25% for rotavirus vaccines and 42% for pneumococcal vaccines</span><span style="font-weight: 400;">.</span></p><p><span style="font-weight: 400;">Vaccine shortages and other crises within countries present further immediate challenges in the context of outbreaks. In 2018 Brazil is facing a shortage of the yellow fever vaccine. Conflict and political instability remain barriers, as can be seen for the last two remaining countries to wipe out polio, Afghanistan and Pakistan. To protect people from VPDs not only are new, improved vaccines needed but also support for the more widespread use of existing vaccines in spite of crisis. This is especially true in low-income countries.</span></p></section>



</div></section>





















</div><footer class="article-footer"><h2 id="footnotes">Footnotes</h2><ol class="footnotes"><li id="note-1"><p>If a high number of the population is vaccinated then it is harder for infectious diseases that are contagious to spread because the number of people that can be infected is lower. This is called </span><a href="http://vk.ovg.ox.ac.uk/herd-immunity" target="_blank" rel="noopener"><span style="font-weight: 400;">‘<em>herd immunity</em>' or '<em>herd protection</em>’</span></a>,<span style="font-weight: 400;"> but this mechanism only works for contagious diseases and not diseases such as tetanus, which is caught from bacteria in the environment and not from other people.</p></li><li id="note-2"><p>In our graphics and visualizations we rely on the <em>Institute for Health Metrics</em> (IHME) ‘<a href="http://ghdx.healthdata.org/gbd-results-tool">Global Burden of Disease Study 2016</a>’ estimates of child death rates from individual VPDs (compared with other causes), TB death rates across countries, and death rates from individual VPDs; this dataset extends back to 1990 and therefore provides a longer-term perspective on these changes over time. However, lack of estimates from the IHME on the role of vaccination in the prevention of deaths means we rely on WHO data for the number of deaths prevented each year through vaccination and the total amount of deaths VPDs are responsible for.</span></p>
<p><span style="font-weight: 400;">The rates reported by the WHO and IHME are in a similar range but do differ slightly. WHO data on individual disease death rates can be found here: <a href="http://www.who.int/gho/mortality_burden_disease/en/" target="_blank" rel="noopener noreferrer">http://www.who.int/gho/mortality_burden_disease/en/</a></span><span style="font-weight: 400;"></p></li><li id="note-3"><p>Note that, as discussed later in this post, the role of vaccines in prevention varies between these causes of death. Measles, for example, has the capacity to be eliminated through vaccination. Diarrheal deaths, in contrast, cannot be eliminated through vaccination alone; hygiene, water services, and nutrition must also be prioritised.</p></li><li id="note-4"><p>Some countries only give measles vaccines combined with rubella (MR) or with varicella in addition (MMRV).</p></li><li id="note-5"><p>Highlighted are </span><span style="font-weight: 400;">10 countries <a href="http://www.who.int/mediacentre/factsheets/fs378/en/">where approximately 60%</a> of these infants live in</span><span style="font-weight: 400;">: Angola, Brazil, the Democratic Republic of the Congo, Ethiopia, India, Indonesia, Iraq, Nigeria, Pakistan, and South Africa.</p></li><li id="note-6"><p>Zwerling A, Behr MA, Verma A, Brewer TF, Menzies D, Pai M. The BCG World Atlas: A Database of Global BCG Vaccination Policies and Practices. </span><i><span style="font-weight: 400;">PLoS Medicine</span></i><span style="font-weight: 400;">. 2011;8(3):e1001012. doi:10.1371/journal.pmed.1001012. Available </span><a href="http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1001012"><span style="font-weight: 400;">here</span></a><span style="font-weight: 400;">.</p></li><li id="note-7"><p>For a detailed commentary on why we do not yet have an effective TB vaccine see: Davenne T, McShane H. Why don’t we have an effective tuberculosis vaccine yet?</span><i><span style="font-weight: 400;"> Expert Review of Vaccines</span></i><span style="font-weight: 400;">. 2016;15(8):1009-1013. doi:10.1586/14760584.2016.1170599. Available </span><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950406/"><span style="font-weight: 400;">here.</span></a><span style="font-weight: 400;"></p></li><li id="note-8"><p>An affordable <em>MenACWYX</em> vaccine is being developed to cover all the types of meningococcal disease (with the exception of meningitis B, which is available through a separate vaccine) and will also have the ability to be transported at higher temperatures. It is currently in phase 1 clinical trial, with the hope that it will be available for use in 2020–2022.</p></li><li id="note-9"><p>See Meningococcal disease in the Middle East and Africa: Findings and updates from the Global Meningococcal Initiative, Borrow, Ray et al. </span><i><span style="font-weight: 400;">Journal of Infection</span></i><span style="font-weight: 400;">, Volume 75 , Issue 1 , 1 - 11. Available </span><a href="http://www.journalofinfection.com/article/S0163-4453(17)30114-7/abstract"><span style="font-weight: 400;">here</span></a><span style="font-weight: 400;">.</p></li><li id="note-10"><p>Susan T Goldstein, Fangjun Zhou, Stephen C Hadler, Beth P Bell, Eric E Mast, Harold S Margolis; A mathematical model to estimate global hepatitis B disease burden and vaccination impact, </span><i><span style="font-weight: 400;">International Journal of Epidemiology</span></i><span style="font-weight: 400;">, Volume 34, Issue 6, 1 December 2005, Pages 1329–1339, </span><a href="https://doi.org/10.1093/ije/dyi206"><span style="font-weight: 400;">https://doi.org/10.1093/ije/dyi206</span></a><span style="font-weight: 400;">. Available </span><a href="https://www.ncbi.nlm.nih.gov/pubmed/16249217"><span style="font-weight: 400;">here</span></a><span style="font-weight: 400;">.</p></li><li id="note-11"><p>Patel M, Shane AL, Parashar UD, Jiang B, Gentsch JR, Glass RI. Oral Rotavirus Vaccines: How Well Will They Work Where They Are Needed Most? T</span><i><span style="font-weight: 400;">he Journal of infectious diseases.</span></i><span style="font-weight: 400;"> 2009;200(0 1):S39-S48. doi:10.1086/605035. Available </span><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3673012/#R1"><span style="font-weight: 400;">here.</span></a><span style="font-weight: 400;"></p></li><li id="note-12"><p>Laxminarayan, Ramanan et al. (2016) – Access to effective antimicrobials: a worldwide challenge.</span><i><span style="font-weight: 400;"> The Lancet</span></i><span style="font-weight: 400;"> Volume 387, Issue 10014, 168 – 175. Available </span><a href="http://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(15)00474-2.pdf"><span style="font-weight: 400;">here</span></a><span style="font-weight: 400;">.</p></li></ol></footer></article></div></main><div id="wpadminbar" style="display:none"><div class="quicklinks" id="wp-toolbar" role="navigation" aria-label="Toolbar"><ul id="wp-admin-bar-root-default" class="ab-top-menu"><li id="wp-admin-bar-site-name" class="menupop"><a class="ab-item" aria-haspopup="true" href="/wp-admin/">Our World In Data</a></li><li id="wp-admin-bar-edit"><a class="ab-item" href="https://owid.mispy.me/wp-admin/post.php?post=18706&amp;action=edit">Edit Post</a></li></ul></div></div><footer class="site-footer"><div class="wrapper"><div class="owid-row"><div class="owid-col owid-col--lg-1"><ul><li><a href="/about">About</a></li><li><a href="/about#contact">Contact</a></li><li><a href="/jobs">Jobs</a></li><li><a href="/about#supporters">Supporters</a></li><li><a href="/about/how-to-use-our-world-in-data">How to use</a></li><li><a href="/donate">Donate</a></li></ul></div><div class="owid-col owid-col--lg-1"><ul><li><a href="/blog">Blog</a></li><li><a href="/charts">All charts</a></li></ul><ul><li><a href="https://twitter.com/OurWorldInData">Twitter</a></li><li><a href="https://www.facebook.com/OurWorldinData">Facebook</a></li><li><a href="https://github.com/owid">GitHub</a></li><li><a href="/feed">RSS Feed</a></li></ul></div><div class="owid-col owid-col--lg-1"><div class="logos"><a href="https://www.oxfordmartin.ox.ac.uk/research/programmes/global-development" class="partner-logo"><img src="/oxford-logo-rect.png" alt="University of Oxford logo"/></a><a href="https://global-change-data-lab.org/" class="partner-logo"><img src="/gcdl-logo.png" alt="Global Change Data Lab logo"/></a><a href="/owid-at-ycombinator" class="partner-logo"><img src="/yc-logo.png" alt="Y Combinator logo"/></a></div></div><div class="owid-col flex-2"><div class="legal"><p>License: All of Our World in Data is completely open access and all work is licensed under the <a href="https://creativecommons.org/licenses/by/4.0/">Creative Commons BY license</a>. You have the permission to use, distribute, and reproduce in any medium, provided the source and authors are credited.</p><p>Please consult our full <a href="/about#legal">legal disclaimer</a>.</p></div></div></div></div><div class="feedbackPromptContainer"></div><script src="https://mispytest-owid.netlify.com/assets/js/commons.js"></script><script src="https://mispytest-owid.netlify.com/assets/js/owid.js"></script><script>
            runHeaderMenus();
            runFeedback();
            Grapher.embedAll();
        </script></footer></body></html>